CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $127,561
- in 3 filings, $17K under 10b5-1 plans
Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-01 | Pinion John Richard | Shares withheld for taxes | −262 | $69.38 | $18K | 49,341 |
| 2020-06-01 | Sharp Shalini CFO & Executive Vice President | Shares withheld for taxes | −348 | $69.38 | $24K | 101,208 |
| 2020-06-01 | Kassberg Thomas Richard CBO & EVP | Shares withheld for taxes | −348 | $69.38 | $24K | 101,740 |
| 2020-06-01 | KAKKIS EMIL D President & CEO | Shares withheld for taxes | −1,334 | $69.38 | $93K | 611,041 |
| 2020-05-26 | Huizenga Theodore Alan SVP, Controller and PAO | Sale | −260 | $74.93 | $19K | 18,331 |
| 2020-05-25 | Huizenga Theodore Alan SVP, Controller and PAO | Shares withheld for taxes | −433 | $73.81 | $32K | 18,591 |
| 2020-05-19 | Sharp Shalini CFO & Executive Vice President | Exercise or conversion | +3,221 | $48.43 | $156K | 104,165 |
| 2020-05-19 | Sharp Shalini CFO & Executive Vice President | Sale | −3,221 | $73.32 | $236K | 100,944 |
| 2020-05-19 | Sharp Shalini CFO & Executive Vice President | Exercise or conversion | +3,907 | $70.57 | $276K | 104,851 |
| 2020-05-19 | Sharp Shalini CFO & Executive Vice President | Sale | −3,907 | $73.32 | $286K | 101,556 |
| 2020-05-19 | Sharp Shalini CFO & Executive Vice President | Exercise or conversion · Stock Option (Right to Buy) | −3,221 | 31,779 | ||
| 2020-05-19 | Sharp Shalini CFO & Executive Vice President | Exercise or conversion · Stock Option (Right to Buy) | −3,907 | 500 | ||
| 2020-05-18 | Aliski William Director | Sale | −20,000 | $74.02 | $1.5M | 70,350 |
| 2020-05-18 | Aliski William Director | Exercise or conversion | +7,500 | $40.37 | $303K | 55,424 |
| 2020-05-18 | Aliski William Director | Sale | −7,500 | $74.65 | $560K | 47,924 |
| 2020-05-18 | Aliski William Director | Exercise or conversion · Stock Option (Right to Buy) | −7,500 | 0 | ||
| 2020-05-18 | Sharp Shalini CFO & Executive Vice President | Exercise or conversion | +19,593 | $70.57 | $1.4M | 122,929 |
| 2020-05-18 | Sharp Shalini CFO & Executive Vice President | Sale | −19,593 | $73.34 | $1.4M | 103,336 |
| 2020-05-18 | Sharp Shalini CFO & Executive Vice President | Sale | −2,392 | $73.29 | $175K | 100,944 |
| 2020-05-18 | Sharp Shalini CFO & Executive Vice President | Exercise or conversion · Stock Option (Right to Buy) | −19,593 | 4,407 |
Page 28 of 32 · 632 trades